The current valuation score of TG Therapeutics Inc is 8.98, ranking 61 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 17.42, which is 1434.00% below the recent high of 267.17 and 2080.89% above the recent low of -345.00.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.